<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E9E5F30-A127-4243-AB12-B19B7A50D0E7"><gtr:id>5E9E5F30-A127-4243-AB12-B19B7A50D0E7</gtr:id><gtr:name>Unlisted</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/03892859-D546-4156-9BE5-CECF1B2689A3"><gtr:id>03892859-D546-4156-9BE5-CECF1B2689A3</gtr:id><gtr:name>Healthy Adolescents &amp; Young Adults (HAYA) Research Unit</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BDB62FBC-921E-49FF-AD56-909ED429E427"><gtr:id>BDB62FBC-921E-49FF-AD56-909ED429E427</gtr:id><gtr:name>Institute of Tropical Medicine</gtr:name><gtr:address><gtr:line1>Nationalestraat 155</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/75C924D5-5134-4F72-AFFE-AD1655EE48F8"><gtr:id>75C924D5-5134-4F72-AFFE-AD1655EE48F8</gtr:id><gtr:name>FHI 360</gtr:name><gtr:address><gtr:line1>359 Blackwell Street</gtr:line1><gtr:line2>Suite 200</gtr:line2><gtr:postCode>27701</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:department>Epidemiology and Population Health</gtr:department><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7"><gtr:id>055EA8B7-2C66-4FF5-96DD-63FA3AA7D0B7</gtr:id><gtr:name>London Sch of Hygiene and Trop Medicine</gtr:name><gtr:address><gtr:line1>Keppel Street</gtr:line1><gtr:postCode>WC1E 7HT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E9E5F30-A127-4243-AB12-B19B7A50D0E7"><gtr:id>5E9E5F30-A127-4243-AB12-B19B7A50D0E7</gtr:id><gtr:name>Unlisted</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/03892859-D546-4156-9BE5-CECF1B2689A3"><gtr:id>03892859-D546-4156-9BE5-CECF1B2689A3</gtr:id><gtr:name>Healthy Adolescents &amp; Young Adults (HAYA) Research Unit</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BDB62FBC-921E-49FF-AD56-909ED429E427"><gtr:id>BDB62FBC-921E-49FF-AD56-909ED429E427</gtr:id><gtr:name>Institute of Tropical Medicine</gtr:name><gtr:address><gtr:line1>Nationalestraat 155</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/75C924D5-5134-4F72-AFFE-AD1655EE48F8"><gtr:id>75C924D5-5134-4F72-AFFE-AD1655EE48F8</gtr:id><gtr:name>FHI 360</gtr:name><gtr:address><gtr:line1>359 Blackwell Street</gtr:line1><gtr:line2>Suite 200</gtr:line2><gtr:postCode>27701</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/734F19C1-61E5-45B1-A183-63FDD145328F"><gtr:id>734F19C1-61E5-45B1-A183-63FDD145328F</gtr:id><gtr:name>World Health Organization (WHO)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/ACCAA472-353D-4CD6-814A-04677AE5E921"><gtr:id>ACCAA472-353D-4CD6-814A-04677AE5E921</gtr:id><gtr:name>MRC/UVRI Uganda Research Unit on AIDS</gtr:name><gtr:address><gtr:line1>Uganda Virus Research Institute</gtr:line1><gtr:line2>51-59 Nakiwogo Road, PO box 49</gtr:line2><gtr:region>Outside UK</gtr:region><gtr:country>Uganda</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1872DC18-5E6F-41D6-9FC3-A619FAD109FB"><gtr:id>1872DC18-5E6F-41D6-9FC3-A619FAD109FB</gtr:id><gtr:firstName>Suzanna</gtr:firstName><gtr:otherNames>Carter</gtr:otherNames><gtr:surname>Francis</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1002369"><gtr:id>9BE10E76-3B7B-46B4-AD44-A494B98757A2</gtr:id><gtr:title>Bacterial vaginosis among women at high risk for HIV in East Africa: the role of behaviour, host immunity, genetics</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G1002369</gtr:grantReference><gtr:abstractText>Around 25 million people are infected with the human immunodeficiency virus (HIV) in sub-Saharan Africa - roughly two-thirds of the worldwide total. The greatest burden is shouldered by 13.3 million African women, who make up 60% of the epidemic in this region. A risk factor for HIV, bacterial vaginosis (BV) is a highly prevalent, reproductive tract infection affecting women. We do not understand the causes of BV or how to control it long-term. 

By further investigating behaviour, genetics, and immunological responses to BV, as well as the bacteria that are associated with BV, we hope to further understand the role of these factors in BV and develop a framework that would help researchers to design interventions to respond to this infection. Though research has shown that some types of behaviour are risk factors for BV, notably intravaginal cleansing and sexual behaviour (e.g. new sex partners, frequency of sexual intercourse without condoms), it seems that behaviour does not completely explain the following questions: why some populations have consistently higher prevalence of BV than others; why some women have recurrent BV and others do not; and why some women have symptoms and others do not. We hope to find answers to these questions that will guide future research on BV with the aim of reducing reproductive health burden and HIV transmission.</gtr:abstractText><gtr:technicalSummary>Aims: 
1) To investigate the role of behavioural, genetic and immunological risk factors for bacterial vaginosis as well as BV-associated bacteria in a population of women at high-risk for HIV in Tanzania.
2) To develop a comprehensive framework for further research related to BV that would include each of the above factors and their interactions, and contribute to the development of interventions against BV. 

Objectives: 
1) To investigate the prevalence of BV in two large observational cohorts, and to identify social and behavioural factors related to BV, symptomatic infection and recurrence
2) To describe the vaginal flora in women with and without BV
3) To investigate the immunological response and gene expression in women with and without BV
4) To finalise a conceptual framework to inform future epidemiological studies investigating BV

Design: Secondary analyses of data from three observational cohorts and the testing and analysis of stored specimens. 

Methodology: This work will exploit the data previously collected from several studies in North-West Tanzania including the EDCTP-funded Women?s Health Project (WHP), the MRC-funded Inflammation Sub-study, and MDP 301 feasibility study. With these data, we will be able to do in-depth analyses of the correlates of BV and recurrence, description and correlates of BV-specific bacteria, and description of immune responses associated with BV or BV-specific bacteria.

In addition, the WHP has preserved 230 CVL cell pellets from participants attending for their 12 month (final) visit. Samples will be sequenced for selected bacteria using semi-quantitative methods, and then tested for human gene expression. 

With the outputs from the above analyses, I will employ advanced epidemiological methods including causal inference and infectious disease modelling to develop a conceptual framework for future research on BV.

Scientific and medical opportunities: Detailed research on BV has not been carried t previously among women at high risk for HIV in sub-Saharan Africa. This research would take advantage of previously collected data to analyse correlates of BV and recurrent BV, identify BV-associated bacteria and obtain detailed data on vaginal mucosal immunity. In addition, we will be able to carry out human genome-wide expression studies that will provide a comprehensive picture of the genes and immune pathways activated during BV. With the outputs from these analyses, I will be able to develop future strategies for research projects including intervention studies on the treatment or prevention of BV with the aim of reducing reproductive health burden and HIV transmission.</gtr:technicalSummary><gtr:fund><gtr:end>2015-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2011-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>441657</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>World Health Organization (WHO)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>STI IPD</gtr:description><gtr:id>1236F3D3-AAF6-422E-9EE9-4BA5280431E5</gtr:id><gtr:impact>A protocol is currently being developed</gtr:impact><gtr:outcomeId>5464ce797d82d5.78128303-1</gtr:outcomeId><gtr:partnerContribution>The WHO will lead on this research.</gtr:partnerContribution><gtr:piContribution>We are providing data for an individual participant data meta-analysis to investigate the prevalence and incidence of STIs in sub-Saharan Africa. Suzanna Francis is on the coordinating group</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC/UVRI Uganda Research Unit on AIDS</gtr:collaboratingOrganisation><gtr:country>Uganda, Republic of</gtr:country><gtr:description>MENISCUS</gtr:description><gtr:id>FE5B3C99-B8AB-469B-9531-B562F338EA07</gtr:id><gtr:impact>We are starting field research in March 2016. We have ethical approval and have trained the team.</gtr:impact><gtr:outcomeId>56df05344a4d16.51571216-1</gtr:outcomeId><gtr:partnerContribution>My partners are co-investigators and have provided intellectual input as well as field based research at the MRC site in Entebbe.</gtr:partnerContribution><gtr:piContribution>MENISCUS is a study investigating the feasibility of conducting a cluster randomized controlled trial to investigate the effect of improved menstrual hygiene management on school attendance among secondary school students in Entebbe, Uganda. A secondary outcome of the planned trial is to investigate the effect of improved menstrual hygiene management on reproductive tract infections. I am leading a sub-study that will investigate the acceptability of vaginal swab sampling among girls in a school setting. We will test the samples for bacterial vaginosis and store samples for future 16SrRNA sequencing.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Healthy Adolescents &amp; Young Adults (HAYA) Research Unit</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>HAYA</gtr:description><gtr:id>CD6422EA-575D-4DCB-8A7A-7840F6BB3523</gtr:id><gtr:impact>A ethics application has been submitted in South Africa and at the London School of Hygiene and Tropical Medicine</gtr:impact><gtr:outcomeId>56df0354bfcfd8.13272015-1</gtr:outcomeId><gtr:partnerContribution>My collaborators are co-investigators on this project, contributing intellectual input and field work at the site in Kwa-Zulu Natal.</gtr:partnerContribution><gtr:piContribution>I am leading on a study to access the feasibility and acceptability of carrying out an survey on reproductive tract infections (including bacterial vaginosis) among young women and men in a demographic surveillance site in Kwa-Zulu Natal, South Africa. We will be collecting samples for testing bacterial vaginosis and storage for future 16SrRNA sequencing. This is the first time to my knowledge that this has been done as a part of a population-based household survey. This is a pilot to apply for future funding to assess physiological risk of HIV infection among young people.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Reading</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>U Reading - Metabolomics</gtr:description><gtr:id>9063664C-0EF1-47CA-B334-1632F249196E</gtr:id><gtr:impact>We have piloted 10 samples with good results.</gtr:impact><gtr:outcomeId>5464b59ccca7d7.75775308-1</gtr:outcomeId><gtr:partnerContribution>Dr Swann will be using nuclear magnetic resonance to obtain a metabolomic profile of 215 samples that have been 16S rRNA sequenced and immune profiling by Luminex.</gtr:partnerContribution><gtr:piContribution>We will be providing samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>FHI 360</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>HC-HIV IPD</gtr:description><gtr:id>FA576D88-7A74-4F5D-B29D-C463D1CB10A4</gtr:id><gtr:impact>Oral presentation at AIDS 2014 (Melbourne, Australia) &amp;quot;Hormonal contraception and HIV infection: results from a large individual participant data meta-analysis&amp;quot; No.THAC0503.

Manuscript under review at PLOS Medicine</gtr:impact><gtr:outcomeId>5464b8d8b08656.89835543-1</gtr:outcomeId><gtr:partnerContribution>FHI 360 is analysing the data and leading on the collaboration</gtr:partnerContribution><gtr:piContribution>We have contributed data to a individual participants data meta-analysis that is investigating the association between hormonal contraception and HIV acquisition in sub-Saharan Africa.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Imperial College - Luminex testing</gtr:description><gtr:id>3FB5D4C4-6E67-4A26-A18F-D812CBC27BF1</gtr:id><gtr:impact>We are now in the process of sending the samples to Imperial College.</gtr:impact><gtr:outcomeId>5464b489b2c6b2.54076659-1</gtr:outcomeId><gtr:partnerContribution>Robin Shattock's group will be carrying out targeted immune profiling using Luminex of the supernatant of the 215 samples sent to the Sanger for 16S rRNA testing.</gtr:partnerContribution><gtr:piContribution>Provided samples</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Institute of Tropical Medicine Antwerp</gtr:collaboratingOrganisation><gtr:country>Belgium, Kingdom of</gtr:country><gtr:department>Unit of Epidemiology and Control of HIV/ STD</gtr:department><gtr:description>RHASA Collaboration</gtr:description><gtr:id>2D04FD4F-4815-4110-AABD-7F7DEA65F394</gtr:id><gtr:impact>New grant to investigate the vaginal microbiome in young girls around the time of sexual debut.</gtr:impact><gtr:outcomeId>hqxJEEQnGHy-1</gtr:outcomeId><gtr:partnerContribution>ITM is leading the project</gtr:partnerContribution><gtr:piContribution>Expertise in the vaginal microbiome; intravaginal practices and research with young women.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>The Sanger - 16S sequencing</gtr:description><gtr:id>6C38B94C-1056-45C8-95CC-A8E7995D7976</gtr:id><gtr:impact>Piloting results</gtr:impact><gtr:outcomeId>X7S4fxvmNeq-1</gtr:outcomeId><gtr:partnerContribution>Alan Walker, post-doc from the Parkhill Group piloted 15 samples on the Roche 454 platform. The Sanger changed platforms to Illumina MiSeq and and 8 samples were piloted comparing different V-regions of the 16S rRNA gene. This piloting worked ended in September 2014 and we have now sent 215 samples for sequencing of the V1-V2 variable regions. Alan Walker has now moved the University of Aberdeen, and we are now collaborating with Josef Wagner.</gtr:partnerContribution><gtr:piContribution>We are providing 215 samples from the last visit from a cohort of women at increased risk for HIV in North-west Tanzania (funded partially by MRC G0701039). We have extensively piloted the v-regions to find the best regions for sequencing vaginal microbiota. We have now sent 215 DNA extracts for sequencing by Julian Parkhill's group.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>150000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Public Health Intervention Development Scheme (Menstrual Hygiene and Safe Male Circumcision Promotion in Ugandan Schools [MENISCUS]: Feasibility and preparatory phase for a cluster randomised trial)</gtr:description><gtr:end>2016-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>9694ABF7-A693-400F-980E-55E45E6D79FF</gtr:id><gtr:outcomeId>56df07875af215.41618573</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1138625</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:department>European and Developing Countries Clinical Trials Partnership</gtr:department><gtr:description>EDCTP Strategic Primer Grant (Preparing for clinical trials of interventions to improve the reproductive health of adolescent girls in sub-Saharan Africa)</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Sixth Framework Programme (FP6)</gtr:fundingOrg><gtr:id>0B24238C-6ADA-41C6-BA1A-C7CA4A08D851</gtr:id><gtr:outcomeId>JqChMYeo5Bj</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>We have combined data from 16SrRNA sequencing of the vaginal microbiota, NMR metabolomics and 33 immune protein targets from 221 women at high risk for HIV in Tanzania</gtr:description><gtr:id>0E23D6E1-1E19-4813-9392-EE2366B6FAAD</gtr:id><gtr:impact>We are analyzing these data.</gtr:impact><gtr:outcomeId>56df1a978d1105.45996079</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>VMB Dataset</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>533C412C-05E1-45AC-A542-524B8638AC1A</gtr:id><gtr:title>Correlates of the molecular vaginal microbiota composition of African women.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5ed47d47e0e5bc3d736f2867b2181759"><gtr:id>5ed47d47e0e5bc3d736f2867b2181759</gtr:id><gtr:otherNames>Gautam R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn><gtr:outcomeId>doi_55faa2aa211d0d1c</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>61064A8C-D049-4AA8-B2D9-89B8A07062AB</gtr:id><gtr:title>Understanding motives for intravaginal practices amongst Tanzanian and Ugandan women at high risk of HIV infection: the embodiment of social and cultural norms and well-being.</gtr:title><gtr:parentPublicationTitle>Social science &amp; medicine (1982)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ab512941caeb1aae2accf5cc6383f6ac"><gtr:id>ab512941caeb1aae2accf5cc6383f6ac</gtr:id><gtr:otherNames>Lees S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0277-9536</gtr:issn><gtr:outcomeId>5464af2457c537.72494965</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DF6495F-2141-49A0-A284-64740B100017</gtr:id><gtr:title>Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c9b83d22fadd99b6ffa7acdc805c189"><gtr:id>9c9b83d22fadd99b6ffa7acdc805c189</gtr:id><gtr:otherNames>Francis SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56defc32ae3373.55040149</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4D88EBD-DA30-4349-B278-330803212A74</gtr:id><gtr:title>Soccer-based promotion of voluntary medical male circumcision: A mixed-methods feasibility study with secondary students in Uganda.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e696ded72138572288b2391729e68b6"><gtr:id>8e696ded72138572288b2391729e68b6</gtr:id><gtr:otherNames>Miiro G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5aa1aa82e42c20.10169572</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94F8F704-0CA5-4C55-924B-5A6F232B8FD7</gtr:id><gtr:title>Sexually transmitted infections: challenges ahead.</gtr:title><gtr:parentPublicationTitle>The Lancet. Infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c14763118da9309cc55098209d81c07f"><gtr:id>c14763118da9309cc55098209d81c07f</gtr:id><gtr:otherNames>Unemo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1473-3099</gtr:issn><gtr:outcomeId>5aa1aa831a7661.40070732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C1A434B-94B4-499B-9032-C971902DA741</gtr:id><gtr:title>Bacterial vaginosis among women at high risk for HIV in Uganda: high rate of recurrent diagnosis despite treatment.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted infections</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c9b83d22fadd99b6ffa7acdc805c189"><gtr:id>9c9b83d22fadd99b6ffa7acdc805c189</gtr:id><gtr:otherNames>Francis SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1368-4973</gtr:issn><gtr:outcomeId>56defc330f95e0.85644698</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4AF4C67-6EBC-463E-B3D5-C60119966061</gtr:id><gtr:title>Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a24619e8e97fd168eadaf7330b096d1"><gtr:id>7a24619e8e97fd168eadaf7330b096d1</gtr:id><gtr:otherNames>Torrone EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5aa1aa833f6853.76456395</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C75E3AA4-9CDC-4908-866B-C51E1E3A9D09</gtr:id><gtr:title>Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e592a67027098903f7c40312ef17e6de"><gtr:id>e592a67027098903f7c40312ef17e6de</gtr:id><gtr:otherNames>Morrison CS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>56defc7da0b0c5.78472447</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEFDF0A6-5F95-40A5-B56E-495D73CC01D6</gtr:id><gtr:title>Menstrual health and school absenteeism among adolescent girls in Uganda (MENISCUS): a feasibility study.</gtr:title><gtr:parentPublicationTitle>BMC women's health</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8e696ded72138572288b2391729e68b6"><gtr:id>8e696ded72138572288b2391729e68b6</gtr:id><gtr:otherNames>Miiro G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1472-6874</gtr:issn><gtr:outcomeId>5aa1aa82a8b099.17461202</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F980A570-6326-4B6E-935A-0A671F9B439A</gtr:id><gtr:title>Prevalence of sexually transmitted infections among young people in South Africa: A nested survey in a health and demographic surveillance site.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c9b83d22fadd99b6ffa7acdc805c189"><gtr:id>9c9b83d22fadd99b6ffa7acdc805c189</gtr:id><gtr:otherNames>Francis SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5aa1aa837265e7.95817732</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B25AC2DE-5044-4C90-AA72-812BA9F82E1B</gtr:id><gtr:title>Factors associated with problem drinking among women employed in food and recreational facilities in northern Tanzania.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/02e83d3885464b0284a30c1288314ca5"><gtr:id>02e83d3885464b0284a30c1288314ca5</gtr:id><gtr:otherNames>Mongi AS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5464af24306059.84179717</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B25569B5-BDD1-4FF9-A13D-EE8FB4CD3BDB</gtr:id><gtr:title>Evaluation of PacBio sequencing for full-length bacterial 16S rRNA gene classification.</gtr:title><gtr:parentPublicationTitle>BMC microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ebbebd92a0fd62aab5ba8726acb881cc"><gtr:id>ebbebd92a0fd62aab5ba8726acb881cc</gtr:id><gtr:otherNames>Wagner J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2180</gtr:issn><gtr:outcomeId>585d3bab14c0b6.26252520</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5D6AA57C-06DF-4D1B-BC7A-A929AA3CA9A2</gtr:id><gtr:title>Vaginal practices among women at high risk of HIV infection in Uganda and Tanzania: recorded behaviour from a daily pictorial diary.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c9b83d22fadd99b6ffa7acdc805c189"><gtr:id>9c9b83d22fadd99b6ffa7acdc805c189</gtr:id><gtr:otherNames>Francis SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14920_20_23555618</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B1F47DD4-C948-45BC-9C62-15F33966C9A7</gtr:id><gtr:title>The vaginal microbiota: what have we learned after a decade of molecular characterization?</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/630e211cab6954bf4d668d807f2258f3"><gtr:id>630e211cab6954bf4d668d807f2258f3</gtr:id><gtr:otherNames>van de Wijgert JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5464af2405bc21.91461937</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED321A9D-FF34-4D7B-9158-8CC7B95312DF</gtr:id><gtr:title>The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cd5e2b4044d48718cb4deb2565d387b"><gtr:id>8cd5e2b4044d48718cb4deb2565d387b</gtr:id><gtr:otherNames>Kapiga SH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14920_20_23874780</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66460FC7-BE85-42D7-9B2A-3EB3856EE60C</gtr:id><gtr:title>Vaginal practices diary: development of a pictorial data collection tool for sensitive behavioral data.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c9b83d22fadd99b6ffa7acdc805c189"><gtr:id>9c9b83d22fadd99b6ffa7acdc805c189</gtr:id><gtr:otherNames>Francis SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>pm_14920_20_22801344</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EB7796B6-040D-482C-8891-87F8E8B18603</gtr:id><gtr:title>ARK: Aggregation of Reads by K-Means for Estimation of Bacterial Community Composition.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c9e06ab57eff794623ced0d95f55aae"><gtr:id>8c9e06ab57eff794623ced0d95f55aae</gtr:id><gtr:otherNames>Koslicki D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56defc32e567a7.65315630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2559D43-B793-4159-B9C2-1D09BB0E88F8</gtr:id><gtr:title>Epidemiology of curable sexually transmitted infections among women at increased risk for HIV in northwestern Tanzania: inadequacy of syndromic management.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9c9b83d22fadd99b6ffa7acdc805c189"><gtr:id>9c9b83d22fadd99b6ffa7acdc805c189</gtr:id><gtr:otherNames>Francis SC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_540e178e178800b6d</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B42057A5-9A0B-4FEC-B525-8C08FE70D217</gtr:id><gtr:title>HIV and other sexually transmitted infections in a cohort of women involved in high-risk sexual behavior in Kampala, Uganda.</gtr:title><gtr:parentPublicationTitle>Sexually transmitted diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f897473d58ac2c3138f8a4905bb83c79"><gtr:id>f897473d58ac2c3138f8a4905bb83c79</gtr:id><gtr:otherNames>Vandepitte J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0148-5717</gtr:issn><gtr:outcomeId>pm_540e178e17874ecd5</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1002369</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>FB395309-E202-4FE8-87B0-041A3D72D4D4</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.5  Research design and methodologies (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>